These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11855567)

  • 21. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
    Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
    Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-parietal cell autoantibodies (PCA) in primary biliary cirrhosis: a putative marker for recurrence after orthotopic liver transplantation?
    Ciesek S; Becker T; Manns MP; Strassburg CP
    Ann Hepatol; 2010; 9(2):181-5. PubMed ID: 20526013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark.
    McCaughan GW; Shackel NA; Strasser SI; Dilworth P; Tang P;
    Liver Transpl; 2010 Feb; 16(2):130-7. PubMed ID: 20104480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplantation; 1998 Apr; 65(8):1044-6. PubMed ID: 9583863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
    Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
    Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of hepatitis C virus after liver transplantation.
    Gugenheim J; Baldini E; Mazza D; Fabiani P; St Paul MC; Goubaux B; Ouzan D; Mouiel J
    Transpl Int; 1994; 7 Suppl 1():S224-6. PubMed ID: 11271209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.
    Hibi T; Nishida S; Sageshima J; Levi DM; Ruiz P; Roth D; Martin P; Okabayashi K; Burke GW; Ciancio G; Tzakis AG
    Transpl Int; 2014 Jun; 27(6):606-16. PubMed ID: 24606223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.
    Zein NN; Rakela J; Poterucha JJ; Steers JL; Wiesner RH; Persing DH
    Liver Transpl Surg; 1995 Nov; 1(6):354-7. PubMed ID: 9346611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus.
    Tanaka A; Kono H; Leung PSC; Gershwin ME
    Cell Immunol; 2020 Jan; 347():104021. PubMed ID: 31767117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors in liver retransplantation: a single-center experience.
    Crivellin C; De Martin E; Germani G; Gambato M; Senzolo M; Russo FP; Vitale A; Zanus G; Cillo U; Burra P
    Transplant Proc; 2011 May; 43(4):1110-3. PubMed ID: 21620065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retransplantation for recurrent hepatitis C.
    Sheiner PA; Schluger LK; Emre S; Thung SN; Lau JY; Guy SR; Schwartz ME; Miller CM
    Liver Transpl Surg; 1997 Mar; 3(2):130-6. PubMed ID: 9346726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease recurrence after liver transplantation in Western Australia.
    Yusoff IF; House AK; De Boer WB; Ferguson J; Garas G; Heath D; Mitchell A; Jeffrey Gp
    J Gastroenterol Hepatol; 2002 Feb; 17(2):203-7. PubMed ID: 11966952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of recurrent primary biliary cirrhosis after liver transplantation.
    Knoop M; Bechstein WO; Schrem H; Lobeck H; Hopf U; Neuhaus P
    Transpl Int; 1996; 9 Suppl 1():S115-9. PubMed ID: 8959806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation and autoimmunity.
    Jaeckel E; Tillmann HL; Manns MP
    Acta Gastroenterol Belg; 1999; 62(3):323-9. PubMed ID: 10547899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo hepatitis C in children after liver transplantation.
    McDiarmid SV; Conrad A; Ament ME; Vargas J; Martin MG; Goss JA; Busuttil RW
    Transplantation; 1998 Aug; 66(3):311-8. PubMed ID: 9721798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P; Busuttil RW; Goldstein RM; Crippin JS; Klintmalm GB; Fitzsimmons WE; Uleman C
    Liver Transpl; 2004 Oct; 10(10):1258-62. PubMed ID: 15376310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.
    Rowe IA; Webb K; Gunson BK; Mehta N; Haque S; Neuberger J
    Transpl Int; 2008 May; 21(5):459-65. PubMed ID: 18225996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.